Skip to main content
. 2016 Nov 24;7:13580. doi: 10.1038/ncomms13580

Figure 6. In vivo demonstration of therapeutic applicability via target VEGF gene silencing.

Figure 6

(a) Change of CEM tumour volume after treatment with reaction buffer, NCsiRNA-ONV, siRNA-Lipo2000, siRNA-TKO or siRNA-ONV through intratumoral delivery. The data error bars indicate means±s.d. (n=5). *P<0.05, **P<0.01 (two-tailed Student’s t-test). (b) Expression of VEGF in CEM tumour tissue sections evaluated by immunofluorescence staining.